PMA P110013S024

Device
RESOLUTE INTEGRITY RX ZOTAROLIMUS ELUTING CORONARY SYSTEM
Applicant
Medtronic Vascular
PMA number
P110013
Supplement
S024
Product code
NIQ
Decision date
2014-02-05
Classification
Coronary Drug-eluting Stent
Generic name
Coronary drug-eluting stent
Approval order statement
APPROVAL FOR A MODIFICATION TO THE RESIDUAL SOLVENTS ANALYTICAL TEST METHOD USED FOR THE TESTING OF THE C10 AND C19 POLYMERS, WHICH ARE A COMPONENT OF THE STENT COATING.

Current openFDA PMA Record#

Device
RESOLUTE INTEGRITY RX ZOTAROLIMUS ELUTING CORONARY SYSTEM
Applicant
Medtronic Vascular
PMA number
P110013
Supplement
S024
Product code
NIQ
Generic name
Coronary drug-eluting stent
Decision date
2014-02-05
Decision code
APPR
Date received
2013-08-09
Supplement type
135 Review Track For 30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Approval order statement
APPROVAL FOR A MODIFICATION TO THE RESIDUAL SOLVENTS ANALYTICAL TEST METHOD USED FOR THE TESTING OF THE C10 AND C19 POLYMERS, WHICH ARE A COMPONENT OF THE STENT COATING.